Kevin J. Black Remove F1000Res Advisory Board  over 8 years ago

Commit id: e406d07dbd5ac53caf9061d9fa6ffabfb2eb56e9

deletions | additions      

       

# Competing interests  KJB: clinical trials supported by Psyadon Pharmaceuticals, Neurocrine Biosciences, Inc., and Acadia Pharmaceuticals; advisory boards: Auspex (past) and Acadia; speakers bureau: Acadia.KJB is an (unpaid) member of the F1000Research Advisory Board.  Both authors have received research funding from the Tourette Association. # Grant information  This work was supported in part by the U.S. National Institutes of Health (NIH), grants K24 MH087913 and R21 NS091635, by a research grant from the Tourette Association of America, and by the McDonnell Center for Systems Neuroscience at Washington University.